Cleveland Clinic surgeon demonstrates complex procedure
Between 4 and 10 percent of renal cell carcinoma patients have tumor thrombi that manifest within the renal vein or inferior vena cava (IVC).
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Surgical treatment of this condition — radical nephrectomy with en bloc vena caval tumor thrombectomy — is challenging and typically has been performed using an open procedure. More recently, surgeons at high-volume centers of excellence have employed laparoscopic or robot-assisted approaches for resection of level I-II tumor thrombi.
Surgeons at Cleveland Clinic’s Glickman Urological & Kidney Institute recently performed the institution’s first robot-assisted level III renal cancer-associated IVC thrombectomy, demonstrating its feasibility in carefully selected patients.
In this five-minute video, Georges Pascal-Haber, MD, PhD, demonstrates each step in the complex robotic procedure, including strategies for success. The surgery was the subject of a presentation at the American Urological Association’s 2016 annual meeting.
Advertisement
Advertisement
Pioneering and refining the approach in pyeloplasty, nephrectomy and more
Unlike earlier pills, new drugs do not cause liver toxicity
Male factors play a role in about half of all infertility cases, yet men often are not evaluated
Hadley Wood, MD, shares her vision as the new editor-in-chief of Urology
Study leverages data from the ROSETTA trial
More on the procedure and the institutional experience
Explain some, but not all, of lower utilization
Study analyzes device biofilms, establishes basis for future developments